Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Clin Pharmacokinet. 2021 Dec;60(12):1635. doi: 10.1007/s40262-021-01055-5.
No abstract available

Publication types

  • Published Erratum